Paragon 28 Net Profit Margin 2020-2022 | FNA

Paragon 28 net profit margin from 2020 to 2022. Net profit margin can be defined as net Income as a portion of total sales revenue.
Paragon 28 Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2022-03-31 $0.11B $-0.02B -14.55%
2021-09-30 $0.10B $-0.00B -4.04%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.281B $0.147B
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.627B 21.80
Edwards Lifesciences (EW) United States $60.552B 42.53
Alcon (ALC) Switzerland $35.080B 30.59
STERIS (STE) Ireland $21.113B 26.67
Fresenius Medical Care AG KGaA (FMS) Germany $14.716B 13.22
Teleflex (TFX) United States $11.964B 19.12
Globus Medical (GMED) United States $5.873B 29.30
Penumbra (PEN) United States $4.736B 299.29
Integer Holdings (ITGR) United States $2.383B 18.51
Glaukos (GKOS) United States $2.256B 0.00
Nevro (NVRO) United States $1.608B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.313B 23.51
Artivion (AORT) United States $0.772B 83.52